Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | yd3 | Crystal structure of human ATAD2 bromodomain in complex with 4-((3R, 4R)-4-3-methyl-5-(5-methylpyridin-3-yl)-2-oxo-1,2-dihydroquinolin-8- yl-aminopiperidin-3-yloxymethyl)-1-thiane-1,1-dione | 5a83 | 64.75 | | 158. |
2 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | kw5 | Crystal structure of human ATAD2 bromodomain in complex with N-(4-bromo-3-((3-methylpiperidin-1-yl)sulfonyl)phenyl)-2-(2,5-dioxoimidazolidin-1-yl)acetamide | 6s55 | 84.76 | | no data |
3 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | kvz | Crystal structure of human ATAD2 bromodomain in complex with N-(4-chloro-3-(N,N-dimethylsulfamoyl)phenyl)-2-(2,5-dioxo-3',4'-dihydro-2'H-spiro[imidazolidine-4,1'-naphthalen]-1-yl)acetamide | 6s56 | 62.33 | | no data |
4 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | kvt | Crystal structure of human ATAD2 bromodomain in complex withN-(3-(azepan-1-ylsulfonyl)-4-methylphenyl)-2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)acetamide | 6s57 | 75.61 | | no data |
5 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g7q | The ATAD2 bromodomain in complex with compound 17 | 6hie | 62.78 | | no data |
6 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g7n | The ATAD2 bromodomain in complex with compound 13 | 6hia | 67.91 | | no data |
7 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g7h | The ATAD2 bromodomain in complex with compound 15 | 6hic | 80.12 | | no data |
8 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g6z | The ATAD2 bromodomain in complex with compound 14 | 6hib | 62.87 | | no data |
9 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g6w | The ATAD2 bromodomain in complex with compound 11 | 6hi8 | 67.85 | | no data |
10 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g6e | The ATAD2 bromodomain in complex with compound 8 | 6hi5 | 57.04 | | no data |
11 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g6b | The ATAD2 bromodomain in complex with compound 10 | 6hi7 | 61.7 | | no data |
12 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g5z | The ATAD2 bromodomain in complex with compound 9 | 6hi6 | 65.23 | | no data |
13 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g5w | The ATAD2 bromodomain in complex with compound 7 | 6hi4 | 69.47 | | no data |
14 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | g1e | The ATAD2 bromodomain in complex with compound 12 | 6ept | 65.44 | | no data |
15 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | fzh | Crystal structure of human ATAD2 bromodomain in complex with 8-(((1R,2R,3R,5S)-2-(2-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)ethyl)-8-azabicyclo[3.2.1]octan-3-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)quinolin-2(1H)-one | 6hdo | 60.24 | | no data |
16 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | bqt | The ATAD2 bromodomain in complex with compound 5 | 6epv | 66.43 | | no data |
17 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | bqk | The ATAD2 bromodomain in complex with compound UZH-DQ41 | 6eps | 62.58 | | no data |
18 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | bqh | The ATAD2 bromodomain in complex with compound 2 | 6epu | 67.48 | | no data |
19 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | bqe | The ATAD2 bromodomain in complex with compound UZH-DS15 | 6epr | 66.17 | | no data |
20 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | bq8 | The ATAD2 bromodomain in complex with compound UZH-DU32 | 6epw | 64.54 | | no data |
21 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | boh | The ATAD2 bromodomain in complex with compound 6 | 6epj | 67.25 | | no data |
22 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | 6xx | Crystal structure of human ATAD2 bromodomain in complex with 8-(((3R,4R,5S)-3-((4,4-difluorocyclohexyl)methoxy)-5-methoxypiperidin-4-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)-1,7-naphthyridin-2(1H)-one | 5lj0 | 65.25 | | 10. |
23 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | thm | Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with thymidine | 4qsv | 68.32 | | 1e+007 |
24 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | 38t | Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with 5-methyl uridine | 4qsw | 71.15 | | 2.1e+007 |
25 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | 38s | Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with 3'-deoxy thymidine | 4qsx | 64.01 | | 1.8e+007 |
26 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | jtf | Crystal structure of human ATAD2 bromodomain in complex with 8-2-(dimethylamino)ethylamino-3-methyl-1,2-dihydroquinolin-2-one | 5a5p | 62.36 | | 100000. |
27 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | 6xc | Crystal structure of human ATAD2 bromodomain in complex with 3-methyl- 8-piperidin-4-ylamino-1,2-dihydro-1,7-naphthyridin-2-one hydrochloride | 5a5q | 62.86 | | 21000. |
28 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | np8 | Crystal structure of human ATAD2 bromodomain in complex with 5-5- methoxypyridin-3-yl-3-methyl-8-piperidin-4-ylamino-1,2-dihydro-1,7- naphthyridin-2-one | 5a5r | 62.81 | | 1260. |
29 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | 78j | Crystal structure of human ATAD2 bromodomain in complex with 8-(3R,4R) -3-(cyclohexylmethoxy)piperidin-4-yl-amino-3-methyl-1,2-dihydro-1,7- naphthyridin-2-one | 5a81 | 67.63 | | 2900. |
30 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | yej | Crystal structure of human ATAD2 bromodomain in complex with 4-(3R,4R) -4-(3-methyl-2-oxo-1,2-dihydro-1,7-naphthyridin-8-yl)aminopiperidin-3- yloxymethyl)-1-thiane-1,1-dione | 5a82 | 71.76 | | 2510. |
31 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | 5qw | Crystal structure of the bromodomain of human ATAD2 in complex with Compound 49 | 5epb | 64.69 | | no data |
32 | ATAD2 | ATPase family AAA domain-containing protein 2 | Q6PL18 | | fzb | Crystal structure of human ATAD2 bromodomain in complex with 3-methyl-8-((8-methyl-8-azabicyclooctan-3-yl)amino)-1,7-naphthyridin-2(1H)-one | 6hdn | 65.06 | | no data |
33 | BAZ2A | Bromodomain adjacent to zinc finger domain protein 2A | Q9UIF9 | KIAA0314 TIP5 | jr4 | Crystal Structure of BAZ2A bromodomain in complex with 1,3-dimethyl-benzimidazolone compound 1 | 5or8 | 56.64 | | no data |
34 | BAZ2A | Bromodomain adjacent to zinc finger domain protein 2A | Q9UIF9 | KIAA0314 TIP5 | d9b | Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 5 | 6fgg | 47.88 | | no data |
35 | BAZ2A | Bromodomain adjacent to zinc finger domain protein 2A | Q9UIF9 | KIAA0314 TIP5 | 6rz | Crystal Structure of BAZ2A bromodomain in complex with 3-amino-2-methylpyridine derivative 1 | 6fgh | 72.91 | | no data |
36 | BAZ2A | Bromodomain adjacent to zinc finger domain protein 2A | Q9UIF9 | KIAA0314 TIP5 | d9k | Crystal Structure of BAZ2A bromodomain in complex with 3-amino-2-methylpyridine derivative 2 | 6fgi | 73.02 | | no data |
37 | BAZ2A | Bromodomain adjacent to zinc finger domain protein 2A | Q9UIF9 | KIAA0314 TIP5 | d9t | Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 3 | 6fgv | 60.41 | | no data |
38 | BAZ2A | Bromodomain adjacent to zinc finger domain protein 2A | Q9UIF9 | KIAA0314 TIP5 | d9q | Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 4 | 6fgw | 55.22 | | no data |
39 | BAZ2A | Bromodomain adjacent to zinc finger domain protein 2A | Q9UIF9 | KIAA0314 TIP5 | en2 | Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 2 | 6fgf | 53.85 | | no data |
40 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | 2lw | Crystal Structure of the bromodomain of human BAZ2B in complex with compound-6 E11322 | 4nra | 61.62 | | 65000. |
41 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | 2lx | Crystal Structure of the bromodomain of human BAZ2B in complex with compound-1 N01197 | 4nrb | 67.62 | | 38000. |
42 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | 54v | Crystal structure of the bromodomain of bromodomain adjacent to zinc finger domain protein 2B (BAZ2B) in complex with 314268-40-1 (SGC - Diamond I04-1 fragment screening) | 5cub | 50.53 | | no data |
43 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | 6rr | Crystal Structure of BAZ2B bromodomain in complex with 3-amino-2-methylpyridine derivative 2 | 5l8t | 76.51 | | 279000. |
44 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | 6rs | Crystal Structure of BAZ2B bromodomain in complex with 3-amino-2-methylpyridine derivative 5 | 5l8u | 75.17 | | no data |
45 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | 6rw | Crystal Structure of BAZ2B bromodomain in complex with 3-amino-2-methylpyridine derivative 3 | 5l97 | 73.77 | | 1e+006 |
46 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | 6ry | Crystal Structure of BAZ2B bromodomain in complex with 3-amino-2-methylpyridine derivative 4 | 5l98 | 74.34 | | 490000. |
47 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | jr5 | Crystal Structure of BAZ2B bromodomain in complex with 1-methyl-cyclopentapyrazole compound 13 | 5or9 | 59.75 | | 88000. |
48 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | jr6 | Crystal Structure of BAZ2B bromodomain in complex with 1-methyl-cyclopentapyrazole compound 30 | 5orb | 55.17 | | 51000. |
49 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | 6rz | Crystal Structure of BAZ2B bromodomain in complex with 3-amino-2-methylpyridine derivative 1 | 5l96 | 83.1 | | 500000. |
50 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | d9t | Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 3 | 6fgt | 52.27 | | no data |
51 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | d9q | Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 4 | 6fgu | 57.07 | | no data |
52 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | KIAA1476 | en2 | Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 2 | 6fh7 | 58.92 | | no data |
53 | BRD1 | Bromodomain-containing protein 1 | O95696 | BRL BRPF2 | 8rv | PanDDA analysis group deposition -- Crystal Structure of BRD1 in complex with N10941a | 5poj | 67.89 | | no data |
54 | BRD1 | Bromodomain-containing protein 1 | O95696 | BRL BRPF2 | 8rv | PanDDA analysis group deposition -- Crystal Structure of BRD1 in complex with N10941a | 5pof | 64.12 | | no data |
55 | BRD1 | Bromodomain-containing protein 1 | O95696 | BRL BRPF2 | 8uj | PanDDA analysis group deposition -- Crystal Structure of BRD1 in complex with N11039a | 5poz | 67.44 | | no data |
56 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | s5b | N-Terminal Bromodomain of Human BRD2 With tbutyl-phenyl-amino- dimethyl-oxazolyl-quinoline-carboxylic acid | 4akn | 64.17 | | 790. |
57 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | jwa | N-terminal bromodomain of human BRD2 with N-((4-(3-(N-cyclopentylsulfamoyl)-4-methylphenyl)-3-methylisoxazol-5-yl)methyl)acetamide inhibitor | 6mo7 | 75.6 | | no data |
58 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | jvy | N-terminal bromodomain of human BRD2 in complex with N-cyclopentyl-7-(3,5-dimethylisoxazol-4-yl)quinoline-5-sulfonamide inhibitor | 6mo9 | 87.84 | | no data |
59 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | hwv | BRD2_Bromodomain2 complex with inhibitor 744 | 6e6j | 82.72 | | no data |
60 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | d7q | Human BRD2 C-terminal bromodomain with 2-((4-acetyl-3-cyclopropyl-3,4-dihydroquinoxalin-1(2H)-yl)methyl)benzoic acid | 6ffe | 66.63 | | no data |
61 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | d7h | Human BRD2 C-terminal bromodomain with (S)-5-(1-acetyl-2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-1,2,3,4-tetrahydroquinoxalin-6-yl)pyrimidine-2-carboxamide | 6fff | 61.77 | | no data |
62 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | d7b | Human BRD2 C-terminal bromodomain with (S)-1-(2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-6-(1,2,3,6-tetrahydropyridin-4-yl)-3,4-dihydroquinoxalin-1(2H)-yl)ethanone | 6ffg | 62.85 | | no data |
63 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | cqf | Crystal structure of BRD2(BD2)with ligand BY27 bound | 6k04 | 65.31 | | no data |
64 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | cqf | Crystal structure of BRD2(BD1)with ligand BY27 bound | 6k05 | 65.39 | | no data |
65 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 9s3 | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-((2R,4S)-2-methyl-4-(phenylamino)-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2H)-yl)ethanone | 4uyh | 57.08 | | 500. |
66 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 73b | C-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A) | 4uyg | 61.54 | | 25. |
67 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 73b | N-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A) | 4uyf | 60.43 | | 25. |
68 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 2lo | Crystal structure of BRD2 second bromodomain in complex with SGC-CBP30 chemical probe | 5bt5 | 55.09 | | no data |
69 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | wsh | Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GW841819X | 2ydw | 62.95 | | 46. |
70 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | eam | Crystal structure of BRD2(BD2) W370F mutant with ligand I-BET 762 bound | 5dfc | 62.22 | | no data |
71 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | eam | Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GSK525762 (IBET) | 2yek | 65.59 | | 61.3 |
72 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 1gh | N-Terminal Bromodomain of Human BRD2 With IBET-151 | 4alg | 69.23 | | 500. |
73 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | p9m | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-cyclopentyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylbenzene-1-sulfonamide | 4a9m | 72.11 | | 500. |
74 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | jq1 | Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor JQ1 | 3oni | 67.13 | | no data |
75 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 1k0 | X-ray crystal structure of bromodomain 2 of human brd2 in complex with rvx208 to 1.08 A resolution | 4j1p | 63.03 | | 90. |
76 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 1k0 | Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (RVX-OH) | 4mr5 | 72.72 | | 251. |
77 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 1k0 | Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (RVX-208) | 4mr6 | 65.91 | | 251. |
78 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 5gd | X-ray crystal structure of human BRD2(BD2) in complex with RVX297 to 1.55 A resolution | 5dw1 | 56.87 | | 80. |
79 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 5p4 | Crystal structure of the second bromodomain of human BRD2 in complex with a tetrahydroquinoline inhibitor | 5ek9 | 69.4 | | 47. |
80 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 8j2 | Crystal structure of the second bromodomain of human BRD2 in complex with a tetrahydroquinoline analogue | 5n2l | 86.64 | | no data |
81 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 31o | Crystal structure of BRD2(BD2) mutant with ligand ME bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]PROPANOATE) | 4qev | 66.39 | | 22. |
82 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 31o | Human Brd2(BD2) mutant in complex with ME | 5o39 | 65.74 | | no data |
83 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 31p | Crystal structure of BRD2(BD2) mutant with ligand ET bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]BUTANOATE) | 4qew | 67.42 | | 86. |
84 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 31p | Human Brd2(BD2) mutant in complex with ET | 5o3a | 74.29 | | no data |
85 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 9hz | Human Brd2(BD2) mutant in complex with AL | 5o3b | 72.02 | | no data |
86 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 9j2 | Human Brd2(BD2) mutant in complex with 9-Me | 5o3c | 67.15 | | no data |
87 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 9j5 | Human Brd2(BD2) mutant in complex with 9-ET | 5o3d | 70.96 | | no data |
88 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 9hw | Human Brd2(BD2) mutant in complex with Me-Am1 | 5o3e | 69.48 | | no data |
89 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 9ht | Human Brd2(BD2) mutant in complex with ET-Am1 | 5o3f | 67.2 | | no data |
90 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 9j8 | Human Brd2(BD2) mutant in complex with AL-Am1 | 5o3g | 66.98 | | no data |
91 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 9hq | Human Brd2(BD2) mutant in complex with 9-ME-Am1 | 5o3h | 69.29 | | no data |
92 | BRD2 | Bromodomain-containing protein 2 | P25440 | KIAA9001 RING3 | 9hn | Human Brd2(BD2) mutant in complex with AL-tBu | 5o3i | 66.57 | | no data |
93 | BRD3 | Bromodomain-containing protein 3 | Q15059 | KIAA0043 RING3L | jq1 | Crystal Structure of the second bromodomain of human BRD3 in complex with the inhibitor JQ1 | 3s92 | 67.73 | | no data |
94 | BRD3 | Bromodomain-containing protein 3 | Q15059 | KIAA0043 RING3L | jq1 | Crystal Structure of the first bromodomain of human BRD3 in complex with the inhibitor JQ1 | 3s91 | 65.29 | | no data |
95 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | x30 | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG048 | 5w55 | 48.2 | | no data |
96 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | x27 | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG056 | 6cj2 | 60.19 | | no data |
97 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | uth | The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand | 4bw2 | 62.36 | | 6310. |
98 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | s5b | The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand | 4bw1 | 62.3 | | 1260. |
99 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | r78 | Crystal structure of the first bromodomain of human BRD4 in complex with BI 2536 | 4o74 | 45.7 | | 25. |
100 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | r78 | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor BI-2536 | 4ogi | 70.76 | | 37. |
101 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | n1d | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 7-(3,4-dimethoxyphenyl)-2-(4-methanesulfonylpiperazine-1-carbonyl)-5-methyl-4H,5H-thieno-3,2-c- pyridin-4-one | 4uiz | 58.89 | | 19950. |
102 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | loc | Joint nentron and X-ray structure of BRD4 in complex with colchicin | 6ajz | 62.67 | | no data |
103 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | loc | Crystal structure of the first bromodomain of BRD4 in complex with 18-Crown-6 | 6in1 | 63.15 | | no data |
104 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | ksz | Crystal Structure of the first bromodomain of BRD4 in complex with a benzodiazepine ligand | 6s25 | 55.44 | | no data |
105 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | jqy | Crystal structure of the first bromodomain of human BRD4 in complex with SKT-68, a 1,4,5-trisubstituted imidazole analogue | 6mh7 | 70.27 | | no data |
106 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | jqp | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH HU-10, A 1,4,5-Trisubstituted Imidazole Analogue | 6mh1 | 70.25 | | no data |
107 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | jbs | Crystal structure of human BRD4(1) in complex with CN210 (compound 19) | 6mau | 54.67 | | no data |
108 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | ies | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH I-BET295 | 4cl9 | 60.54 | | 50. |
109 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | hry | Crystal structure of human BRD4(1) in complex with CN750 | 6e4a | 52.67 | | no data |
110 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | hg8 | Crystal structure of the first bromodomain of human BRD4 in complex with the inhibitor 16k | 6q3z | 59.53 | | no data |
111 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | hg5 | Crystal structure of the first bromodomain of human BRD4 in complex with the inhibitor 16i | 6q3y | 56.01 | | no data |
112 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | hcc | Crystal structure of BRD4 in complex with isoliquiritigenin and DMSO (Cocktail No. 3) | 6ajv | 76.66 | | no data |
113 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | hcc | Crystal structure of BRD4 in complex with isoliquiritigenin in the absence of DMSO | 6ajx | 69.42 | | no data |
114 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | guj | BRD4 bromodomain 1 in complex with HYB157 | 6dl2 | 74.78 | | no data |
115 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | fze | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH : 8-(((1R,2R,3R,5S)-2-(2-(4,4-difluorocyclohexyl)ethyl)-8-azabicyclo[3.2.1]octan-3-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)-1,7-naphthyridin-2(1H)-one | 6hdq | 60.32 | | no data |
116 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | ex1 | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG046 | 6cd4 | 48.44 | | no data |
117 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | e0k | Crystal Structure Analysis of the BRD4 | 5yqx | 74.08 | | no data |
118 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | dzh | FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR #17 | 6fo5 | 61.75 | | no data |
119 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | d7t | Human BRD4 C-terminal bromodomain with 1-(4-(3-methylbenzyl)-3,4-dihydroquinoxalin-1(2H)-yl)ethanone | 6ffd | 74.76 | | no data |
120 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | b0q | Crystal structure of human BRD4(1) bromodomain in complex with UT22B | 5oww | 85.03 | | no data |
121 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | ay2 | Crystal structure of human BRD4(1) bromodomain in complex with DR46 | 5ovb | 58.17 | | no data |
122 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | a0r | Crystal structure of BRD4 in complex with 2',4'-dihydroxy-2-methoxychalcone | 6ajy | 73.08 | | no data |
123 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 9u4 | BRD4-BD1 in complex with Cpd19 (3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-N-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide) | 5vzs | 49.58 | | no data |
124 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 9s3 | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1-(2R,4S)-2-methyl-4-(phenylamino)-6-4-(piperidin-1-ylmethyl)phenyl-1,2,3,4- tetrahydroquinolin-1-yl-ethan-1-one | 5acy | 59.13 | | 6.4 |
125 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 9e3 | Crystal Structure of the first bromodomain of human BRD4 in complex with 5-((4-fluoro-1H-imidazol-1-yl)methyl)quinolin-8-ol | 6afr | 78.29 | | no data |
126 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 9bm | A multiconformer ligand model of 3,5 dimethylisoxaxole bound to the bromodomain of human BRD4 | 6dml | 62.83 | | no data |
127 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 96x | The first bromodomain of BRD4 with compound BDF-1253 | 5z5v | 71.04 | | no data |
128 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8xx | Crystal structure of BRD4-BD1 bound with hjp64 | 5you | 70.27 | | no data |
129 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8xr | Crystal structure of BRD4-BD1 bound with hjp126 | 5yov | 70.14 | | no data |
130 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8q9 | Crystal Structure Analysis of the BRD4 | 5y93 | 57.45 | | no data |
131 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 79c | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH RO3280 | 5vbp | 77.06 | | no data |
132 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 73b | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH GSK1324726A (I-BET726) | 4bjx | 63.08 | | 22. |
133 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 6xx | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 8-(((3R,4R,5S)-3-((4,4-difluorocyclohexyl)methoxy)-5-methoxypiperidin-4-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)-1,7-naphthyridin-2(1H)-one | 5lj1 | 59.71 | | 31600. |
134 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 6xw | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-(5-aminopyridin-3-yl)-8-(((3R,4R)-3-((1,1-dioxidotetrahydro-2H-thiopyran-4-yl)methoxy)piperidin-4-yl)amino)-3-methyl-1,7-naphthyridin-2(1H)-one | 5lj2 | 53.64 | | 10000. |
135 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 6tb | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH DB-1-264-2 | 5kj0 | 54.68 | | 130. |
136 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5w1 | Crystal structure of the first bromodomain of human BRD4 in complex with MA4-022-2 | 5f62 | 59.56 | | 6.8 |
137 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5w0 | Crystal structure of the first bromodomain of human BRD4 in complex with MA4-022-1 | 5f61 | 70.48 | | 35. |
138 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5vz | Crystal structure of the first bromodomain of human BRD4 in complex with SG3-014 | 5f60 | 58.95 | | 43. |
139 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5vy | Crystal structure of the first bromodomain of human BRD4 in complex with MA2-014 | 5f5z | 70.18 | | 86. |
140 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 57g | First bromodomain of BRD4 bound to inhibitor XD29 | 5d3h | 64.52 | | 7900. |
141 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 53w | A multiconformer ligand model of inhibitor 53W bound to CREB binding protein bromodomain | 6dmj | 62.7 | | no data |
142 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 4k4 | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH LRRK2-IN-1 | 5vbo | 53.53 | | no data |
143 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 4k4 | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor XMD11-50 | 5wa5 | 47.47 | | no data |
144 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2ta | Crystal structure of the first bromodomain of human BRD4 in complex with TG101348 | 4ps5 | 56.6 | | 290. |
145 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2ta | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor TG-101348 | 4ogj | 82.1 | | 164. |
146 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2lo | Crystal structure of BRD4 first bromodomain in complex with SGC-CBP30 chemical probe | 5bt4 | 48.4 | | no data |
147 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1m3 | Crystal structure of the first bromodomain of human BRD4 in complex with TG101209 | 4o76 | 84.96 | | 130. |
148 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1a9 | Brd4 Bromodomain 1 complex with 3-CYCLOHEXYL-N-{3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)-5-[(THIOPHEN-2-YLSULFONYL)AMINO]PHENYL}PROPANAMIDE inhibitor | 4hxl | 59.02 | | 2200. |
149 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 0s6 | Crystal structure of the second bromodomain of human BRD4 in complex with MS417 inhibitor | 6duv | 80.73 | | no data |
150 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | wsh | Crystal Structure of the Second Bromodomain of Human Brd4 with the inhibitor GW841819X | 2yem | 67.3 | | 15.5 |
151 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | wsh | Crystal Structure of the First Bromodomain of Human Brd4 with the inhibitor GW841819X | 2yel | 67.43 | | 52.5 |
152 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | cpb | Crystal structure of the first bromodomain of human BRD4 in complex with FLAVOPIRIDOL | 4o71 | 88.16 | | 18000. |
153 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | eam | Crystal Structure of the First Bromodomain of Human Brd4 in complex with IBET inhibitor | 3p5o | 68.55 | | 55.2 |
154 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | wdr | Crystal Structure of the first bromodomain of human BRD4 in complex with a dihydro-quinazolin ligand | 3svf | 69.57 | | no data |
155 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 08h | Crystal Structure of the first bromodomain of human BRD4 in complex with Alprazolam | 3u5j | 74.8 | | 2460. |
156 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 08k | Crystal Structure of the first bromodomain of human BRD4 in complex with a benzo-triazepine ligand (BzT-7) | 3u5l | 74.59 | | 640. |
157 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1gh | Crystal Structure of the first bromodomain of human BRD4 in complex with I-BET151(GSK1210151A) | 3zyu | 69.2 | | 100. |
158 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | p9l | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3-DIMETHYL-6-(MORPHOLINE- 4-SULFONYL)-1,2,3,4-TETRAHYDROQUINAZOLIN-2-ONE | 4a9l | 75.8 | | no data |
159 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 9bm | The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand | 4bw3 | 64.05 | | 500. |
160 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | h4c | Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains | 4c66 | 73.32 | | 79400. |
161 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 83t | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH IBET-295 | 4clb | 59.79 | | 280. |
162 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | jq1 | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JQ1 | 3mxf | 66.54 | | 49. |
163 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 0q1 | Crystal Structure of the first bromodomain of human BRD4 in complex with a isoxazolylbenzimidazole ligand | 4gpj | 72.04 | | no data |
164 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 14z | Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazoline ligand | 4hbw | 77.81 | | 4800. |
165 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 14x | Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolin ligand | 4hbx | 75.34 | | 1900. |
166 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 13f | Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolin ligand | 4hby | 71.19 | | 4400. |
167 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1h2 | Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand | 4j0r | 78.84 | | 386. |
168 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1h3 | Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand | 4j0s | 79.18 | | 382. |
169 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1xb | Structure of BRD4 bromodomain 1 with a dimethyl thiophene isoxazole azepine carboxamide | 4lrg | 68.9 | | no data |
170 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2sj | Crystal Structure of BRD4(1) bound to Colchiceine | 4lys | 72.8 | | 46000. |
171 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 21q | Crystal Structure of BRD4(1) bound to inhibitor XD14 | 4lyw | 62.7 | | 237. |
172 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 25k | Crystal Structure of the first bromodomain of human BRD4 in complex with a 5-methyl-triazolopyrimidine ligand | 4men | 78.15 | | 125000. |
173 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1k0 | Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolinone ligand (RVX-OH) | 4mr3 | 61.79 | | 1142. |
174 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1k0 | Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolinone ligand (RVX-208) | 4mr4 | 59.19 | | 1142. |
175 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1k0 | X-ray crystal structure of bromodomain complex to 1.24 A resolution | 4j3i | 61.36 | | 1800. |
176 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2ll | Crystal structure of the first bromodomain of human BRD4 in complex with an isoxazolyl-benzimidazole ligand | 4nr8 | 58.78 | | no data |
177 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | nue | Crystal structure of the first bromodomain of human BRD4 in complex with MS267 inhibitor | 4nue | 61.9 | | 150. |
178 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2re | Crystal structure of the first bromodomain of human BRD4 in complex with SB 202190 | 4o77 | 61.42 | | 2500. |
179 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | sav | Crystal structure of the first bromodomain of human BRD4 in complex with GW612286X | 4o78 | 71.13 | | 4600. |
180 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2rf | Crystal structure of the first bromodomain of human BRD4 in complex with SB-409514 | 4o7a | 74.99 | | 19000. |
181 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2rj | Crystal structure of the first bromodomain of human BRD4 in complex with SB-284847-BT | 4o7b | 74.21 | | 20000. |
182 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2rk | Crystal structure of the first bromodomain of human BRD4 in complex with SB-614067-R | 4o7c | 59.2 | | 10000. |
183 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2rq | Crystal structure of the first bromodomain of human BRD4 in complex with SB-251527 | 4o7f | 70.6 | | 13000. |
184 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 2n0 | Crystal Structure of the first bromodomain of human BRD4 in complex with compound B13 | 4pce | 75.19 | | 7000. |
185 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 30m | Crystal structure of the first bromodomain of human BRD4 in complex with Olinone | 4qb3 | 77.21 | | 3400. |
186 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | bnj | Brd4 Bromodomain 1 complex with its novel inhibitors | 4qr3 | 66.64 | | 1400. |
187 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | bnk | Brd4 Bromodomain 1 complex with its novel inhibitors | 4qr4 | 63.74 | | 250. |
188 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | bnm | Brd4 Bromodomain 1 complex with its novel inhibitors | 4qr5 | 64.66 | | 60. |
189 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | tvu | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno-3,2-c-pyridine-2- carboxamide | 4uix | 71.06 | | 50.1 |
190 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5v2 | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH N-(1,1-dioxo-1-thian-4-yl)- 5-methyl-4-oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c- pyridine-2-carboximidamide | 4uiy | 71.39 | | 2510. |
191 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 3ot | Direct photocapture of bromodomains using tropolone chemical probes | 4whw | 61.51 | | no data |
192 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 3p2 | Crystal Structure of the first bromodomain of human BRD4 in complex with a novel inhibitor UMB32 (N-TERT-BUTYL-2-[4-(3,5-DIMETHYL-1,2-OXAZOL-4-YL) PHENYL]IMIDAZO[1,2-A]PYRAZIN-3-AMINE) | 4wiv | 63.1 | | 550. |
193 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 3x0 | Discovery of benzotriazolo diazepines as orally-active inhibitors of BET bromodomains: Crystal structure of BRD4 with CPI-13 | 4x2i | 75.67 | | 350. |
194 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | y80 | Crystal structure of human BRD4(1) in complex with 4-[(2E)-3-(4-methoxyphenyl)-2-phenylprop-2-enoyl]-3,4-dihydroquinoxalin-2(1H)-one (compound 19a) | 4yh3 | 66.44 | | 26000. |
195 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | y81 | Crystal structure of human BRD4(1) in complex with 4-[(5-phenylpyridin-3-yl)carbonyl]-3,4-dihydroquinoxalin-2(1H)-one (compound 19d) | 4yh4 | 71.42 | | 26000. |
196 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 4ld | BRD4 bromodomain 2 in complex with gamma-carboline-containing compound, number 18. | 4z93 | 68.46 | | 44.6 |
197 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 4v1 | Crystal structure of hBRD4 in complex with BL-BI06 reveals a novel synthesized inhibitor that induces Beclin1-independent/ATG5-dependent autophagic cell death in breast cancer | 4zw1 | 69.22 | | no data |
198 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | np8 | NN-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-5-methoxypyridin-3-yl-3- methyl-8-piperidin-4-ylamino-1,2-dihydro-1,7-naphthyridin-2-one | 5a5s | 66.19 | | 1260. |
199 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 78j | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 8-(3R,4R)-3-(cyclohexylmethoxy)piperidin-4-ylamino-3-methyl-1,2-dihydro-1,7- naphthyridin-2-one | 5a85 | 67.8 | | 5010. |
200 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | etu | Bivalent binding to BET bromodomains | 5ad2 | 92.22 | | no data |
201 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 4wg | BRD4 in complex with ERK5 inhibitor XMD8-92 | 5lrq | 52.42 | | no data |
202 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 53w | Selective pharmacological inhibition of the CREB binding protein bromodomain regulates inflammatory cytokines in macrophages and RGS4 in neurons | 5cfw | 62.11 | | no data |
203 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | e0b | Crystal Structure of the first bromodomain of human BRD4 in complex with benzo[cd]indol-2(1H)-one ligand | 5d0c | 70.52 | | 2340. |
204 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | l26 | First bromodomain of BRD4 bound to inhibitor XD26 | 5d24 | 77.64 | | 5800. |
205 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 56m | First bromodomain of BRD4 bound to inhibitor XD27 | 5d25 | 67.37 | | 500. |
206 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | l28 | First bromodomain of BRD4 bound to inhibitor XD28 | 5d26 | 62.58 | | 810. |
207 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | l33 | First bromodomain of BRD4 bound to inhibitor XD33 | 5d3j | 63.76 | | 5700. |
208 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 57f | First bromodomain of BRD4 bound to inhibitor XD35 | 5d3l | 58.52 | | 880. |
209 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | l40 | First bromodomain of BRD4 bound to inhibitor XD40 | 5d3n | 69.53 | | 9200. |
210 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 57e | First bromodomain of BRD4 bound to inhibitor XD41 | 5d3p | 70.56 | | 7400. |
211 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 57c | First bromodomain of BRD4 bound to inhibitor XD42 | 5d3r | 62.75 | | no data |
212 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 579 | First bromodomain of BRD4 bound to inhibitor XD44 | 5d3s | 68.86 | | 1300. |
213 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 56y | First bromodomain of BRD4 bound to inhibitor XD47 | 5d3t | 75.53 | | 12000. |
214 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5d2 | FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-1-{3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}piperidine-4-carboxamide | 5dlx | 63.95 | | 2000. |
215 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5d1 | FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 4-[(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)oxy]-N-({1-[(3-methylphe methyl]piperidin-4-yl}methyl)butanamide | 5dlz | 52 | | 1800. |
216 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5gd | X-ray crystal structure of human BRD4(BD1) in complex with RVX297 to 1.12 A resolution | 5dw2 | 51.78 | | 1440. |
217 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5nq | FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 3-Butyl-8-(6-butyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-ylsulfanylmethyl)-7-ethyl-3,7-dihydropurine-2,6-dione | 5egu | 62.31 | | 1400. |
218 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5nv | First domain of human bromodomain BRD4 in complex with inhibitor 8-(5-Amino-1H-[1,2,4]triazol-3-ylsulfanylmethyl)-3-(4-chlorobenzyl)-7-ethyl-3,7-dihydropurine-2,6-dione | 5ei4 | 77.34 | | 26400. |
219 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5ou | FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 3-(4-Chlorobenzyl)-7-ethyl-3,7-dihydropurine-2,6-dione | 5eis | 78.21 | | 1800. |
220 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | loc | Crystal Structure of BRD4(1) bound to Colchicine | 4lzr | 63.01 | | 20000. |
221 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5w4 | Crystal structure of the first bromodomain of human BRD4 in complex with PNZ5 isoxazole inhibitor | 5fbx | 72.38 | | no data |
222 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | rmr | Trimethoxy-ring inhibitor in complex with the first bromodomain of BRD4 | 5h21 | 73.17 | | 6400. |
223 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 62g | Crystal structure of the first bromodomain of human BRD4 bound to CPI-0610 | 5hls | 70.95 | | 39. |
224 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 62v | Crystal structure of the first bromodomain of human BRD4 bound to benzoisoxazoloazepine 3 | 5hm0 | 75.24 | | 440. |
225 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 64s | Crystal structure of fragment bound with Brd4 | 5hq7 | 76.35 | | no data |
226 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 69g | BRD4 in complex with Cpd4 ((E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide) | 5i88 | 75.22 | | 250. |
227 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | bmf | Crystal structure of the first bromodomain of human BRD4 in complex with bromosporine (BSP) | 5igk | 72.05 | | 41.8 |
228 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 6rx | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIHYDROPYRIDOPYRIMIDINE SCAFFOLD INHIBITOR | 5kdh | 70.32 | | no data |
229 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 6xh | BRD4 bromodomain in complex with Cpd59 ((S)-1-(3-((2-fluoro-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-5(4H)-yl)ethanone) | 5ku3 | 58.11 | | 13000. |
230 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 1qk | Crystal structure of the first bromodomain of human BRD4 in complex with DINACICLIB | 4o70 | 78.29 | | 19000. |
231 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 77x | Structure of the first bromodomain of BRD4 with a pyrazolo[4,3-c]pyridin fragment | 5luu | 76.71 | | 8630. |
232 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 7e7 | Crystal structure of BRD4 BROMODOMAIN 1 IN COMPLEX WITH LIGAND 2 | 5m3a | 71.48 | | 2000. |
233 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | rnk | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 4-chloro-2-methyl-5-(((3-methylthiophen-2-yl)methyl)amino)pyridazin-3(2H)-one | 5mkz | 78.29 | | no data |
234 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8j2 | Crystal structure of the first bromodomain of human BRD4 in complex with a tetrahydroquinoline analogue | 5n2m | 67.04 | | no data |
235 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 08j | Crystal Structure of the first bromodomain of human BRD4 in complex with Midazolam | 3u5k | 71.48 | | no data |
236 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 837 | BRD4 first bromodomain (BD1) in complex with dual PI3 kinase (PI3K) inhibitor SF2535 | 5u2e | 62.11 | | 277. |
237 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 82y | BRD4 first bromodomain (BD1) in complex with dual PI3 kinase (PI3K) inhibitor SF2558HA | 5u2f | 61.45 | | 193. |
238 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 87g | BRD4_BD2_A-1395017 | 5ueo | 81.18 | | no data |
239 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 87m | BRD4_BD2_A-1390146 | 5ueq | 81.98 | | no data |
240 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 87p | BRD4_BD2_A-1359930 | 5uer | 82.33 | | no data |
241 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 87s | BRD4_BD2_A-1344772 | 5ues | 70.39 | | no data |
242 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 0s6 | Crystal structure of the first bromodomain of human BRD4 in complex with MS417 inhibitor | 4f3i | 67.09 | | 36.1 |
243 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 0s6 | BRD4_BD2_A-1107604 | 5ueu | 66.38 | | 16.7 |
244 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 89d | BRD4_BD2_A-1497627 | 5uex | 78.47 | | 1.5 |
245 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 88m | BRD4_BD2_A-1412838 | 5uey | 77.88 | | 5.1 |
246 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 89g | BRD4_BD2_A-1342843 | 5uez | 73.45 | | 970. |
247 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 89j | BRD4_BD2-A-35165 | 5uf0 | 75.75 | | 160000. |
248 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 5mj | Crystal Structure of the First Bromodomain of Human BRD4 in Complex With Cyclic Vinylogous Amide Inhibitor MS402 | 5ula | 56.2 | | 77. |
249 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8nv | BRD4_BD2_A-1454056 | 5uvt | 77.26 | | no data |
250 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8o4 | BRD4_BD2_A-1461028 | 5uvu | 76.81 | | no data |
251 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8ns | BRD4 Bromodomain 2 with A-1457066 | 5uvv | 77.1 | | no data |
252 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8ng | BRD4_Bromodomain1-A1376855 | 5uvw | 87.95 | | no data |
253 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8nj | BRD4 Bromodomain 2 with A-1349391 | 5uvy | 71.46 | | no data |
254 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 9gy | Benzopiperazine BET bromodomain inhibitor in complex with BD1 of Brd4 | 5vom | 65.48 | | 790. |
255 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 6je | N-terminal bromodomain of BRD4 in complex with OTX-015 | 5wmd | 58.19 | | no data |
256 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 6jf | N-terminal bromodomain of BRD4 in complex with OTX-015 | 5wmg | 71.6 | | no data |
257 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 7uu | Complex structure of the first bromodomain of BRD4 with an inhibitor that containing a 2H-chromen-2-one ring | 5wuu | 73.85 | | 810. |
258 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8f9 | BRD4 bound with compound Bdi2 | 5xi2 | 70.56 | | no data |
259 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8f6 | BRD4 bound with compound Bdi3 | 5xi3 | 72.71 | | no data |
260 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | 8f0 | BRD4 bound with compound Bdi4 | 5xi4 | 70.34 | | no data |
261 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | eo1 | BRD4 BD2 in complex with compound CE277 | 6c7q | 65.23 | | no data |
262 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | eo4 | BRD4 BD1 in complex with compound CF53 | 6c7r | 66.76 | | no data |
263 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | fp7 | BRD4(BD1) complexed with 3219 | 6czu | 73.5 | | no data |
264 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | foy | BRD4(BD1) complexed with 2759 | 6czv | 75.41 | | no data |
265 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | dyz | FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR F1 | 6fnx | 78.19 | | no data |
266 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | e5q | Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand | 6fsy | 77.45 | | no data |
267 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | e5t | Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand | 6ft3 | 77.76 | | no data |
268 | BRD4 | Bromodomain-containing protein 4 | O60885 | HUNK1 | e5w | Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand | 6ft4 | 72.84 | | no data |
269 | BRD7 | Bromodomain-containing protein 7 | Q9NPI1 | BP75 CELTIX1 | 5u6 | Crystal structure of the BRD7 bromodomain in complex with BI-9564 | 5mq1 | 75.53 | | no data |
270 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | n1d | BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-2-(4- methanesulfonylpiperazine-1-carbonyl)-5-methyl-4H,5H-thieno-3,2-c- pyridin-4-one | 4uit | 65.09 | | 200. |
271 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | 6b2 | Crystal structure of human BRD9 bromodomain in complex with LP99 chemical probe | 5ign | 65.54 | | no data |
272 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | 67c | BRD9 bromodomain in complex with 3-(6-(but-3-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide | 6bqa | 71.21 | | no data |
273 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | xzb | BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide | 4uiv | 66.41 | | 15.8 |
274 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | h1b | BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide | 4uiw | 67.27 | | 50. |
275 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | tvu | BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1- thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno-3,2-c-pyridine-2-carboxamide | 4uiu | 67.94 | | 12.6 |
276 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | 5sw | CRYSTAL STRUCTURE OF BRD9 IN COMPLEX WITH BI-7273 | 5eu1 | 70.43 | | 15.4 |
277 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | 5u2 | Crystal structure of the bromodomain of BRD9 in complex with compound 9. | 5f1l | 74.89 | | 21. |
278 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | 5ty | Crystal structure of the BRD9 bromodomain in complex with compound 3. | 5f2p | 79.06 | | 37500. |
279 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | 69g | BRD9 in complex with Cpd4 ((E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide) | 5i7y | 69.86 | | 52. |
280 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | bmf | Crystal structure of the bromodomain of human BRD9 in complex with bromosporine (BSP) | 5igm | 71.61 | | 41.7 |
281 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | i0d | BROMODOMAIN OF HUMAN BRD9 WITH 4-chloro-2-methyl-5-((2-methyl-1,2,3,4-tetrahydroisoquinolin-5-yl)amino)pyridazin-3(2H)-one | 5mky | 77.66 | | no data |
282 | BRD9 | Bromodomain-containing protein 9 | Q9H8M2 | | 5u6 | Crystal structure of the BRD9 bromodamian in complex with BI-9564. | 5f1h | 73.03 | | 14.1 |
283 | BRDT | Bromodomain testis-specific protein | Q58F21 | | r78 | CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRDT IN COMPLEX WITH BI2536 | 5vbq | 54.75 | | no data |
284 | BRDT | Bromodomain testis-specific protein | Q58F21 | | jq1 | Crystal Structure of the first bromodomain of human BRDT in complex with the inhibitor JQ1 | 4flp | 65.44 | | 190.1 |
285 | BRDT | Bromodomain testis-specific protein | Q58F21 | | 1qk | BRDT in complex with Dinaciclib | 4kcx | 62.86 | | 37000. |
286 | BRPF1 | Peregrin | P55201 | BR140 | 9f9 | BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide | 4uye | 67.66 | | 9.54 |
287 | BRPF1 | Peregrin | P55201 | BR140 | 5gv | Crystal structure of the human BRPF1 bromodomain in complex with SEED5 | 5dya | 81.83 | | 200000. |
288 | BRPF1 | Peregrin | P55201 | BR140 | 5sb | Crystal structure of the human BRPF1 bromodomain in complex with SEED15 | 5ev9 | 67.77 | | no data |
289 | BRPF1 | Peregrin | P55201 | BR140 | 5s9 | Crystal structure of the human BRPF1 bromodomain in complex with SEED16 | 5eva | 71.8 | | 200000. |
290 | BRPF1 | Peregrin | P55201 | BR140 | 5sk | Crystal structure of the human BRPF1 bromodomain in complex with SEED21 | 5eww | 66.1 | | no data |
291 | BRPF1 | Peregrin | P55201 | BR140 | 5xf | Crystal structure of the bromodomain of human BRPF1 in complex with PFI-4 chemical probe | 5fg5 | 68.42 | | no data |
292 | BRPF1 | Peregrin | P55201 | BR140 | lf1 | BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide | 5g4r | 66.19 | | no data |
293 | BRPF1 | Peregrin | P55201 | BR140 | 8vi | BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-N- ethyl-2-methoxybenzamide | 5g4s | 60.66 | | no data |
294 | BRPF1 | Peregrin | P55201 | BR140 | bmf | Crystal structure of the human BRPF1 bromodomain in complex with Bromosporine | 5c7n | 63.59 | | 270. |
295 | BRPF1 | Peregrin | P55201 | BR140 | uwx | Crystal structure of the human BRPF1 bromodomain in complex with BZ089 | 5mwh | 61.74 | | no data |
296 | BRPF1 | Peregrin | P55201 | BR140 | kgu | Crystal structure of the human BRPF1 bromodomain in complex with BZ073 | 5mwz | 57.17 | | no data |
297 | BRPF1 | Peregrin | P55201 | BR140 | 9l5 | Crystal structure of the human BRPF1 bromodomain in complex with BZ047 | 5o55 | 62.42 | | no data |
298 | BRPF1 | Peregrin | P55201 | BR140 | 9ln | Crystal structure of the human BRPF1 bromodomain in complex with BZ032 | 5o5a | 63.71 | | no data |
299 | BRPF1 | Peregrin | P55201 | BR140 | 9lt | Crystal structure of the human BRPF1 bromodomain in complex with BZ038 | 5o5f | 57.02 | | no data |
300 | BRPF1 | Peregrin | P55201 | BR140 | 9lk | Crystal structure of the human BRPF1 bromodomain in complex with BZ053 | 5o5h | 70.22 | | no data |
301 | BRPF1 | Peregrin | P55201 | BR140 | axn | Crystal structure of the human BRPF1 bromodomain in complex with BZ097 | 5ov8 | 60.98 | | no data |
302 | BRPF1 | Peregrin | P55201 | BR140 | b0h | Crystal structure of the human BRPF1 bromodomain complexed with BZ054 in space group C2 | 6ekq | 65.92 | | no data |
303 | BRPF1 | Peregrin | P55201 | BR140 | b0h | Crystal structure of the human BRPF1 bromodomain in complex with BZ054 | 5owa | 72.16 | | no data |
304 | CBP | CREB-binding protein | Q92793 | CBP | bkj | CREBBP bromodomain in complex with Cpd 30 (1-(3-(3-(1-methyl-1H-pyrazol-4-yl)isoquinolin-8-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) | 6alb | 63.82 | | no data |
305 | CBP | CREB-binding protein | Q92793 | CBP | ay2 | Crystal structure of CREBBP bromodomain complexd with DR46 | 6fqt | 82.4 | | no data |
306 | CBP | CREB-binding protein | Q92793 | CBP | 9ud | CREBBP Bromodomain in complex with Cpd10 (1-(3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) | 5w0l | 63 | | no data |
307 | CBP | CREB-binding protein | Q92793 | CBP | 9u4 | CREBBP bromodomain in complex with Cpd19 (3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-N-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide) | 5w0e | 63.66 | | no data |
308 | CBP | CREB-binding protein | Q92793 | CBP | 69b | Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02857790 | 5i89 | 74.71 | | 33. |
309 | CBP | CREB-binding protein | Q92793 | CBP | 69a | Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02778174 | 5i86 | 78.99 | | 530. |
310 | CBP | CREB-binding protein | Q92793 | CBP | 5qn | Crystal structure of the bromodomain of human CREBBP in complex with UP39 | 5eng | 57.49 | | no data |
311 | CBP | CREB-binding protein | Q92793 | CBP | 2lo | Crystal structure of the bromodomain of human CREBBP in complex with an isoxazolyl-benzimidazole ligand | 4nr7 | 64.65 | | no data |
312 | CBP | CREB-binding protein | Q92793 | CBP | 2ll | A multiconformer ligand model of an isoxazolyl-benzimidazole ligand bound to the bromodomain of human CREBBP | 6dmk | 60.96 | | no data |
313 | CBP | CREB-binding protein | Q92793 | CBP | 2lk | Crystal structure of the bromodomain of human CREBBP in complex with an isoxazolyl-benzimidazole ligand | 4nr4 | 87.77 | | no data |
314 | CBP | CREB-binding protein | Q92793 | CBP | 2ln | Crystal structure of the bromodomain of human CREBBP in complex with an oxazepin ligand | 4nr6 | 58.09 | | no data |
315 | CBP | CREB-binding protein | Q92793 | CBP | 2ll | Crystal structure of the bromodomain of human CREBBP in complex with an isoxazolyl-benzimidazole ligand | 4nr5 | 62.65 | | no data |
316 | CBP | CREB-binding protein | Q92793 | CBP | 2o3 | Crystal Structure of the Bromodomain of human CREBBP in complex with a dihydroquinoxalinone ligand | 4nyw | 74.99 | | no data |
317 | CBP | CREB-binding protein | Q92793 | CBP | 2o4 | Crystal Structure of the Bromodomain of human CREBBP in complex with a dihydroquinoxalinone ligand | 4nyx | 68.83 | | no data |
318 | CBP | CREB-binding protein | Q92793 | CBP | ul4 | Crystal structure of the bromodomain of human CREBBP in complex with UL04 | 4tqn | 77.53 | | 770. |
319 | CBP | CREB-binding protein | Q92793 | CBP | 3ot | BROMO domain of CREB binding protein | 4whu | 66.13 | | no data |
320 | CBP | CREB-binding protein | Q92793 | CBP | 53w | Selective pharmacological inhibition of the CREB binding protein bromodomain regulates inflammatory cytokines in macrophages and RGS4 in neurons | 5cgp | 67.7 | | no data |
321 | CBP | CREB-binding protein | Q92793 | CBP | 5qr | Crystal structure of the bromodomain of human CREBBP in complex with UN32 | 5ep7 | 68.9 | | no data |
322 | CBP | CREB-binding protein | Q92793 | CBP | 5xs | Crystal structure of the bromodomain of human CREBBP in complex with UO37D | 5h85 | 67.44 | | no data |
323 | CBP | CREB-binding protein | Q92793 | CBP | 68y | Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02773986 | 5i83 | 74.6 | | 4100. |
324 | CBP | CREB-binding protein | Q92793 | CBP | 6f9 | Crystal structure of the bromodomain of human CREBBP in complex with a benzoxazepine compound | 5j0d | 59.34 | | 134. |
325 | CBP | CREB-binding protein | Q92793 | CBP | 6xb | Crystal structure of the bromodomain of human CREBBP bound to pyrazolopiperidine scaffold | 5ktu | 85.88 | | 620. |
326 | CBP | CREB-binding protein | Q92793 | CBP | 6xg | CREBBP bromodomain in complex with Cpd 44 (3-((5-acetyl-1-(cyclopropylmethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-yl)amino)-N-isopropylbenzamide) | 5ktw | 65.24 | | 30. |
327 | CBP | CREB-binding protein | Q92793 | CBP | 6xh | CREBBP bromodomain in complex with Cpd59 ((S)-1-(3-((2-fluoro-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-5(4H)-yl)ethanone) | 5ktx | 67.96 | | 20. |
328 | CBP | CREB-binding protein | Q92793 | CBP | xdm | Crystal structure of the bromodomain of human CREBBP bound to the inhibitor XDM1 | 5lpj | 74.3 | | 10100. |
329 | CBP | CREB-binding protein | Q92793 | CBP | 71x | Crystal structure of the bromodomain of human CREBBP bound to the inhibitor XDM3c | 5lpl | 73.34 | | 12000. |
330 | CBP | CREB-binding protein | Q92793 | CBP | 77x | Structure of bromodomain of CREBBP with a pyrazolo[4,3-c]pyridin fragment | 5tb6 | 76.37 | | 1530. |
331 | CBP | CREB-binding protein | Q92793 | CBP | 96n | Crystal structure of the human bromodomain of CREBBP bound to the inhibitor XDM4 | 5nrw | 73.86 | | no data |
332 | CBP | CREB-binding protein | Q92793 | CBP | 99e | Crystal structure of the human bromodomain of CREBBP bound to the inhibitor XDM-CBP | 5nu3 | 82.34 | | 230. |
333 | CBP | CREB-binding protein | Q92793 | CBP | 9u7 | CREBBP Bromodomain in complex with Cpd3 ((S)-1-(3-(6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-1-(tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) | 5w0f | 66.09 | | no data |
334 | CBP | CREB-binding protein | Q92793 | CBP | 9ua | CREBBP Bromodomain in complex with Cpd8 (1-(3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-1-(tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) | 5w0i | 63.43 | | no data |
335 | CBP | CREB-binding protein | Q92793 | CBP | 9ug | CREBBP Bromodomain in complex with Cpd17 (N,2,7-trimethyl-2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carboxamide) | 5w0q | 73.75 | | no data |
336 | CBP | CREB-binding protein | Q92793 | CBP | e0d | Crystal Structure Analysis of the CBP | 5xxh | 65.54 | | no data |
337 | CBP | CREB-binding protein | Q92793 | CBP | e3t | Crystal structure of CREBBP bromodomain complexd with PA10 | 6frf | 83.74 | | no data |
338 | EP300 | Histone acetyltransferase p300 | Q09472 | P300 | 2lo | Crystal structure of EP300 bromodomain in complex with SGC-CBP30 chemical probe | 5bt3 | 61.95 | | no data |
339 | EP300 | Histone acetyltransferase p300 | Q09472 | P300 | xdm | Crystal structure of the bromodomain of human EP300 bound to the inhibitor XDM1 | 5lpk | 86.44 | | 3060. |
340 | EP300 | Histone acetyltransferase p300 | Q09472 | P300 | 71y | Crystal structure of the bromodomain of human Ep300 bound to the inhibitor XDM3d | 5lpm | 81.27 | | 2770. |
341 | EP300 | Histone acetyltransferase p300 | Q09472 | P300 | 99e | Crystal structure of the human bromodomain of EP300 bound to the inhibitor XDM-CBP | 5nu5 | 75.3 | | 470. |
342 | KAT2A | Histone acetyltransferase KAT2A | Q92830 | GCN5 GCN5L2 | b8o | Crystal structure of the human GCN5 bromodomain in complex with compound (R,R)-36n | 6j3p | 66.79 | | no data |
343 | KAT2A | Histone acetyltransferase KAT2A | Q92830 | GCN5 GCN5L2 | 9st | Bromodomain of Human GCN5 with 4-bromo-2-methyl-5-(((3R,5R)-1-methyl-5-phenylpiperidin-3-yl)amino)pyridazin-3(2H)-one | 5mlj | 72.49 | | no data |
344 | KAT2B | Histone acetyltransferase KAT2B | Q92831 | PCAF | b4l | Crystal structure of the human PCAF bromodomain in complex with compound 12 | 6j3o | 82.31 | | no data |
345 | KAT2B | Histone acetyltransferase KAT2B | Q92831 | PCAF | 2lx | Crystal structure of human PCAF bromodomain in complex with compound-D (CPD-D), N-methyl-2-(tetrahydro-2H-pyran-4-yloxy)benzamide | 5lvq | 81.04 | | 73000. |
346 | KAT2B | Histone acetyltransferase KAT2B | Q92831 | PCAF | 5x0 | Crystal structure of human PCAF bromodomain in complex with compound BDOMB00091a (compound 14) | 5fdz | 69.06 | | 6800. |
347 | KAT2B | Histone acetyltransferase KAT2B | Q92831 | PCAF | p2l | Bromodomain of Mouse PCAF with (R)-4-chloro-2-methyl-5-((1-methylpiperidin-3-yl)amino)pyridazin-3(2H)-one | 5ml0 | 85.7 | | no data |
348 | PB1 | Protein polybromo-1 | Q86U86 | BAF180 PB1 | 5xk | Crystal structure of the fifth bromodomain of human PB1 in complex with compound 28 | 5fh8 | 80.44 | | 170. |
349 | PB1 | Protein polybromo-1 | Q86U86 | BAF180 PB1 | 2xd | Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand | 4q0n | 82.23 | | no data |
350 | PB1 | Protein polybromo-1 | Q86U86 | BAF180 PB1 | 2xc | Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand | 4q0o | 68.17 | | no data |
351 | PB1 | Protein polybromo-1 | Q86U86 | BAF180 PB1 | lu2 | Crystal Structure of the fifth bromodomain of human polybromo (PB1) in complex with 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one | 5ii2 | 90.36 | | 12900. |
352 | PB1 | Protein polybromo-1 | Q86U86 | BAF180 PB1 | 5xm | Crystal structure of the fifth bromodomain of human PB1 in complex with compound 10 | 5fh6 | 73.69 | | 1200. |
353 | PB1 | Protein polybromo-1 | Q86U86 | BAF180 PB1 | 5xl | Crystal structure of the fifth bromodomain of human PB1 in complex with compound 18 | 5fh7 | 84.13 | | 137. |
354 | PB1 | Protein polybromo-1 | Q86U86 | BAF180 PB1 | 6bk | Crystal Structure of the fifth bromodomain of human polybromo (PB1) in complex with 2-(3,4-dihydroxyphenyl)-5-hydroxy-4H-chromen-4-one | 5iid | 88.97 | | no data |
355 | PHIP | PH-interacting protein | Q8WWQ0 | DCAF14 WDR11 | 5qd | Crystal structure of the second bromodomain of Pleckstrin homology domain interacting protein (PHIP) in complex with N-(2,6-Dichlorobenzyl)acetamide (SGC - Diamond I04-1 fragment screening) | 5enc | 68.53 | | 5e+006 |
356 | SMCA2 | Probable global transcription activator SNF2L2 | P51531 | BAF190B BRM SNF2A SNF2L2 | 5bw | Crystal structure of the bromodomain of human BRM (SMARCA2) in complex with PFI-3 chemical probe | 5dkc | 73.68 | | no data |
357 | SMCA2 | Probable global transcription activator SNF2L2 | P51531 | BAF190B BRM SNF2A SNF2L2 | 5c0 | Crystal structure of the bromodomain of human BRM (SMARCA2) in complex with a hydroxyphenyl propenone inhibitor 17 | 5dkh | 69.74 | | no data |
358 | SMCA4 | Transcription activator BRG1 | P51532 | BAF190A BRG1 SNF2B SNF2L4 | 5bw | Crystal structure of the bromodomain of human BRG1 (SMARCA4) in complex with PFI-3 chemical probe | 5dkd | 70.44 | | no data |
359 | TAF1 | Transcription initiation factor TFIID subunit 1 | P21675 | BA2R CCG1 CCGS TAF2A | g9y | TAF1-BD2 in complex with Cpd8 (6-(but-3-en-1-yl)-4-(3-(morpholine-4-carbonyl)phenyl)-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one) | 6df4 | 82.21 | | no data |
360 | TAF1 | Transcription initiation factor TFIID subunit 1 | P21675 | BA2R CCG1 CCGS TAF2A | g9v | TAF1-BD2 in complex with Cpd27 (6-(but-3-en-1-yl)-4-(1-methyl-6-(morpholine-4-carbonyl)-1H-benzo[d]imidazol-4-yl)-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one) | 6df7 | 75.56 | | no data |
361 | TAF1 | Transcription initiation factor TFIID subunit 1 | P21675 | BA2R CCG1 CCGS TAF2A | 69g | TAF1-BD2 bromodomain in complex with (E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide | 6bqd | 83.93 | | no data |
362 | TAF1 | Transcription initiation factor TFIID subunit 1 | P21675 | BA2R CCG1 CCGS TAF2A | 67c | Second bromodomain of TAF1 bound to a pyrrolopyridone compound | 5i1q | 81.35 | | 12. |
363 | TAF1L | Transcription initiation factor TFIID subunit 1-like | Q8IZX4 | | bmf | Crystal structure of the second bromodomain of human TAF1L in complex with bromosporine (BSP) | 5igl | 66.69 | | 42.7 |
364 | TIF1A | Transcription intermediary factor 1-alpha | O15164 | RNF82 TIF1 TIF1A | 4bv | Crystal structure of TRIM24 PHD-bromodomain complexed with N-{1,3-dimethyl-2-oxo-6-[3-(oxolan-3-ylmethoxy)phenoxy]-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-1-methyl-1H-imidazole-4-sulfonamide (7l) | 4ybt | 63.96 | | 100. |
365 | TIF1A | Transcription intermediary factor 1-alpha | O15164 | RNF82 TIF1 TIF1A | 4bk | Crystal structure of TRIM24 PHD-bromodomain complexed with N-{1,3-dimethyl-6-[3-(2-methylpropoxy)phenoxy]-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-1,2-dimethyl-1H-imidazole-4-sulfonamide (7g) | 4ybs | 61.32 | | 57. |